SCRN1: A cerebrospinal fluid biomarker correlating with tau in Alzheimer's disease
Sophia Weiner(Institute of Neurobiology), Johan Gobom(Sahlgrenska University Hospital), Julius Constantinescu(University of Gothenburg), Gunnar Brinkmalm(University of Gothenburg), Bárbara Fernandes Gomes(University of Gothenburg), Kaj Blennow(Sahlgrenska University Hospital), Mathias Sauer(Sahlgrenska University Hospital), Bengt Nellgård(Sahlgrenska University Hospital), Keti Dalla(Sahlgrenska University Hospital), Douglas Galasko(University of California San Diego), Bruno Becker(Sahlgrenska University Hospital), Henrik Zetterberg(Queen Mary University of London), Radu Constantinescu(Sahlgrenska University Hospital)
Cited by 9
Related Papers
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Diagnosis and management of dementia with Lewy bodies
|Neurology|2017|4.4k
Defeating Alzheimer's disease and other dementias: a priority for European science and society
|The Lancet Neurology|2016|1.7k